These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1167514)

  • 1. Tetrahydroaminoacridine antagonism to narcotic addiction.
    Albin MS; Orr MD; Bunegin L; Henderson PA
    Exp Neurol; 1975 Mar; 46(3):644-8. PubMed ID: 1167514
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade with methadone, cyclazocine, and naloxone.
    Freedman AM; Zaks A; Resnick R; Fink M
    Int J Addict; 1970 Sep; 5(3):507-15. PubMed ID: 5524385
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of experimental drug addiction with antibodies to serotonin and dopamine].
    Evseev VA; Basharova LA; Vetrilé LA; Trekova NA; Igon'kina SI; Mikovskaia OI
    Biull Eksp Biol Med; 1996 Aug; 122(8):189-92. PubMed ID: 9081475
    [No Abstract]   [Full Text] [Related]  

  • 4. Heroin addiction and the role of methadone in its treatment.
    Goldstein A
    Arch Gen Psychiatry; 1972 Apr; 26(4):291-7. PubMed ID: 4622401
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary study of fresh juice of Benincasa hispida on morphine addiction in mice.
    Grover JK; Rathi SS; Vats V
    Fitoterapia; 2000 Dec; 71(6):707-9. PubMed ID: 11077182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
    Wikler A
    Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
    [No Abstract]   [Full Text] [Related]  

  • 7. Addiction and the community. (Narcotic substitution therapy).
    Taylor WJ; Chambers CD; Bowling CE
    Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
    [No Abstract]   [Full Text] [Related]  

  • 8. The theoretical basis of narcotic addiction treatment with narcotic antagonists.
    Wikler A
    NIDA Res Monogr; 1976 Sep; (9):119-22. PubMed ID: 1004530
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal-human correlates of narcotic dependence: a brief review.
    Stimmel B; Glick SD
    Am J Psychiatry; 1978 Jul; 135(7):821-5. PubMed ID: 96703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auricular acupuncture in animals: effects of opiate withdrawal and involvement of endorphins.
    Ng LK
    J Altern Complement Med; 1996; 2(1):61-3; discussion 73-5. PubMed ID: 9395644
    [No Abstract]   [Full Text] [Related]  

  • 11. Outpatient barbiturate withdrawal using phenobarbital.
    Gray GR; Smith DE; Wesson DR; Sheppard CW
    Int J Addict; 1972; 7(1):17-26. PubMed ID: 5043836
    [No Abstract]   [Full Text] [Related]  

  • 12. Propranolol in the treatment of opiate dependence -- a controlled study.
    Jacob RG; Holmstrand J; Eriksson JH; Anggård E
    Psychopharmacologia; 1975; 41(1):71-3. PubMed ID: 1091940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing acute withdrawal syndrome on patients with heroin and morphine addiction by acupuncture therapy.
    Lu PK; Lu GP; Lu DP; Lu DP; Lu WI
    Acupunct Electrother Res; 2004; 29(3-4):187-95. PubMed ID: 15807100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XXVII. Opioid addiction problems in Canada.
    Holmes SJ
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():347-58. PubMed ID: 5723802
    [No Abstract]   [Full Text] [Related]  

  • 15. Narcotic antagonists in the treatment of opiate dependence.
    Fink M; Zaks A; Resnick RB; Freedman AM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on morphine. IX. On the intensity of the abstinence syndrome to morphine induced by daily injections of nalorphine in white mice.
    Huidobro F; Maggiolo C
    Arch Int Pharmacodyn Ther; 1965 Nov; 158(1):97-112. PubMed ID: 5892561
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
    Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
    Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narcotic antagonists: another approach to addiction therapy.
    Fink M; Freedman AM; Zaks AM; Resnick RB
    Am J Nurs; 1971 Jul; 71(7):1359-63. PubMed ID: 5207098
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
    Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
    Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutical potentialities of rapid opioid detoxification].
    Sivolap IuP
    Anesteziol Reanimatol; 2002; (6):55-8. PubMed ID: 12611160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.